EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 262 filers reported holding EDITAS MEDICINE INC in Q3 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $748,107 | +27.5% | 90,900 | +12.4% | 0.01% | +8.3% |
| Q1 2023 | $586,525 | -19.8% | 80,900 | -1.9% | 0.01% | 0.0% |
| Q4 2022 | $731,775 | -27.5% | 82,500 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $1,010,000 | -50.9% | 82,500 | -52.6% | 0.01% | -50.0% |
| Q2 2022 | $2,058,000 | -80.7% | 174,000 | -32.8% | 0.03% | -77.0% |
| Q3 2021 | $10,644,000 | -54.8% | 259,100 | -37.6% | 0.12% | -60.3% |
| Q2 2021 | $23,533,000 | +60.2% | 415,500 | +18.8% | 0.31% | -2.8% |
| Q1 2021 | $14,692,000 | +498.7% | 349,800 | +899.4% | 0.32% | +464.3% |
| Q4 2020 | $2,454,000 | +218.3% | 35,000 | +27.3% | 0.06% | +211.1% |
| Q3 2020 | $771,000 | -66.4% | 27,500 | -76.3% | 0.02% | -86.2% |
| Q1 2020 | $2,296,000 | – | 115,800 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
| Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
| Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
| Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
| Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
| EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
| Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
| VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
| Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |